Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Low-dose High-resolution 18F-FDG-PET/CT Using Time-of-flight and Point-spread Function Reconstructions: A Role in the Detection of Breast Carcinoma Axillary Lymph Node Metastases

E. Ferdová, J. Baxa, A. Ňaršanská, O. Hes, J. Fínek, O. Topolčan, J. Ferda,

. 2018 ; 38 (7) : 4145-4148.

Language English Country Greece

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc18033017

AIM: to evaluate the performance of N-staging assessment in clinically-proven T1 breast carcinoma by high-resolution 18F-fluorodeoxyglucose-positron-emission tomography/computed tomography (18F-FDG-PET/CT) using time-of-flight with point-spread function reconstruction. PATIENTS AND METHODS: In 30 women with clinically proven T1 breast carcinoma, imaging before surgery was performed using 18F-FDG-PET/CT. The results of PET/CT in detection of lymph node metastases were compared with those obtained after pathological investigation of axillary biopsy. A four-ring PET subsystem with image reconstruction using time-of-flight and point-spread function was used with the radiopharmaceutical dose reduction to 2.5 MBq/kg. RESULTS: Axillary lymph node metastasis was confirmed by histology in 13 patients, but metastasis was suspected based on PET/CT in 12 of those patients, the absence of metastasis was surgically confirmed in 17 women, 15 of which were suspected based on PET/CT. The sensitivity for detection of axillary lymph node metastasis was 93.3%, with a specificity of 88.2% in the whole patient cohort. Additionally, distant metastatic spread was found in 13.3% of patients. CONCLUSION: The reconstruction of PET images with time-of-flight and point-spread function enabled the improvement of diagnostic performance in N-staging of breast carcinoma, even when the dose of radiopharmaceutical was reduced to 2.5 MBq/kg.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18033017
003      
CZ-PrNML
005      
20181009105646.0
007      
ta
008      
181008s2018 gr f 000 0|eng||
009      
AR
024    7_
$a 10.21873/anticanres.12706 $2 doi
035    __
$a (PubMed)29970542
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Ferdová, Eva $u Department of Imaging Methods, Charles University Hospital Pilsen, Pilsen, Czech Republic ferdovae@fnplzen.cz.
245    10
$a Low-dose High-resolution 18F-FDG-PET/CT Using Time-of-flight and Point-spread Function Reconstructions: A Role in the Detection of Breast Carcinoma Axillary Lymph Node Metastases / $c E. Ferdová, J. Baxa, A. Ňaršanská, O. Hes, J. Fínek, O. Topolčan, J. Ferda,
520    9_
$a AIM: to evaluate the performance of N-staging assessment in clinically-proven T1 breast carcinoma by high-resolution 18F-fluorodeoxyglucose-positron-emission tomography/computed tomography (18F-FDG-PET/CT) using time-of-flight with point-spread function reconstruction. PATIENTS AND METHODS: In 30 women with clinically proven T1 breast carcinoma, imaging before surgery was performed using 18F-FDG-PET/CT. The results of PET/CT in detection of lymph node metastases were compared with those obtained after pathological investigation of axillary biopsy. A four-ring PET subsystem with image reconstruction using time-of-flight and point-spread function was used with the radiopharmaceutical dose reduction to 2.5 MBq/kg. RESULTS: Axillary lymph node metastasis was confirmed by histology in 13 patients, but metastasis was suspected based on PET/CT in 12 of those patients, the absence of metastasis was surgically confirmed in 17 women, 15 of which were suspected based on PET/CT. The sensitivity for detection of axillary lymph node metastasis was 93.3%, with a specificity of 88.2% in the whole patient cohort. Additionally, distant metastatic spread was found in 13.3% of patients. CONCLUSION: The reconstruction of PET images with time-of-flight and point-spread function enabled the improvement of diagnostic performance in N-staging of breast carcinoma, even when the dose of radiopharmaceutical was reduced to 2.5 MBq/kg.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a axila $7 D001365
650    _2
$a karcinom $x diagnostické zobrazování $x patologie $7 D002277
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fluorodeoxyglukosa F18 $7 D019788
650    _2
$a lidé $7 D006801
650    _2
$a interpretace obrazu počítačem $x metody $7 D007090
650    _2
$a lymfatické metastázy $x diagnostické zobrazování $x patologie $7 D008207
650    _2
$a lidé středního věku $7 D008875
650    _2
$a staging nádorů $x metody $7 D009367
650    _2
$a PET/CT $7 D000072078
650    _2
$a radiofarmaka $7 D019275
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a triple-negativní karcinom prsu $x diagnostické zobrazování $x patologie $7 D064726
655    _2
$a časopisecké články $7 D016428
700    1_
$a Baxa, Jan $u Department of Imaging Methods, Charles University Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Ňaršanská, Andrea $u Department of Surgery, Charles University Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Hes, Ondřej $u Šikl´s Institute of Pathologic Anatomy, Charles University Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Fínek, Jindřich $u Department of Oncology and Radiotherapy, Charles University Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Topolčan, Onřej $u Immunoanalytic Laboratory, Charles University Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Ferda, Jiří $u Department of Imaging Methods, Charles University Hospital Pilsen, Pilsen, Czech Republic.
773    0_
$w MED00000478 $t Anticancer research $x 1791-7530 $g Roč. 38, č. 7 (2018), s. 4145-4148
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29970542 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20181009110134 $b ABA008
999    __
$a ok $b bmc $g 1339986 $s 1030011
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 38 $c 7 $d 4145-4148 $i 1791-7530 $m Anticancer research $n Anticancer Res $x MED00000478
LZP    __
$a Pubmed-20181008

Find record

Citation metrics

Archiving options